BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15259648)

  • 1. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
    Das SK; Miften MM; Zhou S; Bell M; Munley MT; Whiddon CS; Craciunescu O; Baydush AH; Wong T; Rosenman JG; Dewhirst MW; Marks LB
    Med Phys; 2004 Jun; 31(6):1452-61. PubMed ID: 15259648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of Functional Lung Heterogeneity and Dosimetry to Radiation Pneumonitis using Perfusion SPECT/CT and FDG PET/CT Imaging.
    Lee HJ; Zeng J; Vesselle HJ; Patel SA; Rengan R; Bowen SR
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):1255-1264. PubMed ID: 30108002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography for radiation treatment planning.
    Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
    Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation.
    Zhou SM; Wong TZ; Marks LB
    Med Phys; 2004 Sep; 31(9):2577-83. PubMed ID: 15487740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integration of computerized tomography imaging with single photon emission in a commercial system for developing radiotherapy fields: application to conformational irradiation for lung carcinoma].
    Cattaneo GM; Rizzo G; Lombardi P; Ceresoli G; Savi A; Gilardi MC; Villa E; Calandrino R
    Radiol Med; 1999 Apr; 97(4):272-8. PubMed ID: 10414261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
    Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose painting by numbers in a standard treatment planning system using inverted dose prescription maps.
    Arnesen MR; Knudtsen IS; Rekstad BL; Eilertsen K; Dale E; Bruheim K; Helland Å; Løndalen AM; Hellebust TP; Malinen E
    Acta Oncol; 2015; 54(9):1607-13. PubMed ID: 26213311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study of shrinking field radiation therapy based on (18)F-FDG PET/CT for stage III non-small cell lung cancer.
    Ding X; Li H; Wang Z; Huang W; Li B; Zang R; Sun H; Yi Y
    Technol Cancer Res Treat; 2013 Jun; 12(3):251-7. PubMed ID: 23289475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosimetric implications of the addition of 18 fluorodeoxyglucose-positron emission tomography in CT-based radiotherapy planning for non-small-cell lung cancer.
    Vinod SK; Kumar S; Holloway LC; Shafiq J
    J Med Imaging Radiat Oncol; 2010 Apr; 54(2):152-60. PubMed ID: 20518880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].
    Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
    Cancer Radiother; 2005 Sep; 9(5):304-15. PubMed ID: 16087377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects.
    Munley MT; Marks LB; Scarfone C; Sibley GS; Patz EF; Turkington TG; Jaszczak RJ; Gilland DR; Anscher MS; Coleman RE
    Lung Cancer; 1999 Feb; 23(2):105-14. PubMed ID: 10217614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A feasibility study of 18F-fluorodeoxyglucose positron emission tomography targeting and simultaneous integrated boost for intensity-modulated radiosurgery and radiotherapy.
    Solberg TD; Agazaryan N; Goss BW; Dahlbom M; Lee SP
    J Neurosurg; 2004 Nov; 101 Suppl 3():381-9. PubMed ID: 15537193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Gaussian mixture model for definition of lung tumor volumes in positron emission tomography.
    Aristophanous M; Penney BC; Martel MK; Pelizzari CA
    Med Phys; 2007 Nov; 34(11):4223-35. PubMed ID: 18072487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-18-FDG-PET confined radiotherapy of locally advanced NSCLC with concomitant chemotherapy: results of the PET-PLAN pilot trial.
    Fleckenstein J; Hellwig D; Kremp S; Grgic A; Gröschel A; Kirsch CM; Nestle U; Rübe C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e283-9. PubMed ID: 21470782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of hybrid fluorodeoxyglucose positron-emission tomography/computed tomography on radiotherapy planning in esophageal and non-small-cell lung cancer.
    Gondi V; Bradley K; Mehta M; Howard A; Khuntia D; Ritter M; Tomé W
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):187-95. PubMed ID: 17189070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
    Devic S; Mohammed H; Tomic N; Aldelaijan S; De Blois F; Seuntjens J; Lehnert S; Faria S
    Br J Radiol; 2016 Jun; 89(1062):20150388. PubMed ID: 27007269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Workflow and radiation safety implications of (18)F-FDG PET/CT scans for radiotherapy planning.
    Sam S; Shon IH; Vinod SK; Lin P; Lin M
    J Nucl Med Technol; 2012 Sep; 40(3):175-7. PubMed ID: 22582005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.